ProAssurance Co. (NYSE:PRA - Free Report) - Research analysts at Zacks Research raised their Q1 2025 earnings per share estimates for shares of ProAssurance in a research report issued on Wednesday, November 27th. Zacks Research analyst K. Dey now expects that the insurance provider will earn $0.17 per share for the quarter, up from their previous estimate of $0.16. The consensus estimate for ProAssurance's current full-year earnings is $0.76 per share. Zacks Research also issued estimates for ProAssurance's Q2 2025 earnings at $0.19 EPS, Q3 2025 earnings at $0.20 EPS, FY2025 earnings at $0.78 EPS, Q1 2026 earnings at $0.18 EPS, Q2 2026 earnings at $0.20 EPS, Q3 2026 earnings at $0.22 EPS and FY2026 earnings at $0.85 EPS.
Several other equities research analysts also recently issued reports on the stock. Truist Financial raised their price objective on shares of ProAssurance from $14.00 to $18.00 and gave the stock a "hold" rating in a research report on Tuesday, November 12th. StockNews.com lowered ProAssurance from a "buy" rating to a "hold" rating in a report on Tuesday, November 19th. Finally, Piper Sandler cut shares of ProAssurance from an "overweight" rating to a "neutral" rating and set a $18.00 target price for the company. in a research report on Monday, November 11th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $18.67.
Get Our Latest Stock Analysis on PRA
ProAssurance Stock Up 0.4 %
PRA stock traded up $0.06 during midday trading on Monday, hitting $16.78. The company's stock had a trading volume of 147,981 shares, compared to its average volume of 279,766. The company's fifty day moving average price is $15.58 and its 200 day moving average price is $13.86. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.28 and a quick ratio of 0.28. ProAssurance has a twelve month low of $10.76 and a twelve month high of $17.79. The stock has a market capitalization of $858.40 million, a P/E ratio of 20.18 and a beta of 0.24.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in the company. Deerfield Management Company L.P. Series C boosted its stake in shares of ProAssurance by 199.4% during the second quarter. Deerfield Management Company L.P. Series C now owns 80,425 shares of the insurance provider's stock valued at $983,000 after purchasing an additional 53,560 shares during the period. Allspring Global Investments Holdings LLC increased its position in shares of ProAssurance by 1.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,311,435 shares of the insurance provider's stock valued at $19,724,000 after acquiring an additional 18,718 shares during the period. Assenagon Asset Management S.A. raised its stake in shares of ProAssurance by 2.4% during the second quarter. Assenagon Asset Management S.A. now owns 253,649 shares of the insurance provider's stock valued at $3,100,000 after acquiring an additional 6,062 shares during the last quarter. Public Sector Pension Investment Board boosted its holdings in shares of ProAssurance by 6.1% during the second quarter. Public Sector Pension Investment Board now owns 112,203 shares of the insurance provider's stock worth $1,371,000 after purchasing an additional 6,437 shares during the period. Finally, AQR Capital Management LLC grew its stake in shares of ProAssurance by 25.7% in the second quarter. AQR Capital Management LLC now owns 243,834 shares of the insurance provider's stock worth $2,980,000 after purchasing an additional 49,851 shares during the last quarter. Institutional investors own 85.58% of the company's stock.
About ProAssurance
(
Get Free Report)
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Read More
Before you consider ProAssurance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProAssurance wasn't on the list.
While ProAssurance currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
